 <h1>Hydrochlorothiazide / olmesartan Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to hydrochlorothiazide / olmesartan: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Drugs that act directly on the renin-angiotensin system can cause injury or death to the developing fetus when used during pregnancy. Stop therapy as soon as possible if pregnancy is detected.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, hydrochlorothiazide/olmesartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking hydrochlorothiazide / olmesartan:</p><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>chest pain</li>
<li>difficult, burning, or painful urination</li>
<li>flushed, dry skin</li>
<li>frequent urge to urinate</li>
<li>fruit-like breath odor</li>
<li>increased hunger</li>
<li>increased urination</li>
<li>joint pain, stiffness, or swelling</li>
<li>lower back, side, or stomach pain</li>
<li>rapid weight gain</li>
<li>sweating</li>
<li>swelling of the feet or lower legs</li>
<li>tingling of the hands or feet</li>
<li>troubled breathing</li>
<li>unexplained weight loss</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Swelling or puffiness of the face</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Convulsions</li>
<li>decrease in amount of urine</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>rash</li>
<li>severe diarrhea with weight loss</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of hydrochlorothiazide / olmesartan may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>difficulty with breathing</li>
<li>ear congestion or pain</li>
<li>fever</li>
<li>headache</li>
<li>head congestion</li>
<li>hoarseness or other voice changes</li>
<li>loss of voice</li>
<li>runny or stuffy nose</li>
<li>sneezing</li>
<li>sore throat</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>difficulty with moving</li>
<li>dizziness or lightheadedness</li>
<li>feeling of constant movement of self or surroundings</li>
<li>heartburn</li>
<li>indigestion</li>
<li>joint pain, stiffness, or swelling</li>
<li>loss of appetite</li>
<li>muscle pain or stiffness</li>
<li>pain, swelling, or redness in the joints</li>
<li>sensation of spinning</li>
<li>stomach discomfort or upset</li>
<li>weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Diarrhea</li>
<li>muscle pain or stiffness</li>
<li>nervousness</li>
<li>weakness or heaviness of the legs</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hydrochlorothiazide / olmesartan: oral tablet</i></p><h3>General</h3><p>The most common side effect was dizziness.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p><b>Postmarketing reports</b>: Lightheadedness, paresthesia</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Dizziness, headache<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Bronchitis, pharyngitis, sinusitis, upper respiratory tract infection, coughing, nasopharyngitis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Bronchitis, nasopharyngitis, pharyngitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Sinusitis, upper respiratory tract infection, cough</p>
<p><b>Frequency not reported</b>: Pneumonitis, pulmonary edema</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Bronchitis, nasopharyngitis, sinusitis, upper respiratory tract infection, cough, pharyngitis, rhinitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo, Influenza-like symptoms, chest pain, fatigue, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Weakness</p>
<p><b>Postmarketing reports</b>: Asthenia, lethargy, malaise</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Vertigo, influenza-like symptoms</p>
<p><b>Uncommon</b> (0.1% to 1%): Chest pain, fatigue, peripheral edema</p>
<p><b>Frequency not reported</b>: Weakness, fever</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Vertigo, chest pain, fatigue, influenza-like symptoms, peripheral edema, pain</p>
<p><b>Postmarketing reports</b>: Asthenia, lethargy, malaise<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastroenteritis, nausea, abdominal pain, dyspepsia</p>
<p><b>Postmarketing reports</b>: Sprue-like enteropathy, vomiting</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dyspepsia, nausea, gastroenteritis</p>
<p><b>Frequency not reported</b>: Sialadenitis, cramping, gastric irritation</p>
<p><b>Postmarketing reports</b>: Constipation</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, nausea, gastroenteritis, abdominal pain</p>
<p><b>Postmarketing reports</b>: Vomiting, sprue-like enteropathy<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, creatine phosphokinase increased, arthralgia, arthritis, myalgia</p>
<p><b>Uncommon</b> (0.1% to 1%): Pain in limb, spinal disorder</p>
<p><b>Postmarketing reports</b>: Rhabdomyolysis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Arthralgia, back pain, pain in limb</p>
<p><b>Uncommon</b> (0.1% to 1%): Spinal disorder</p>
<p><b>Frequency not reported</b>: Muscle spasm</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Arthralgia, back pain, pain in limb, arthritis, skeletal pain, creatine phosphokinase increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Spinal disorder, myalgia</p>
<p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperlipemia, hyperglycemia, blood uric acid increased, hyperuricemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood glucose increased, blood potassium decreased, blood potassium increased, hypertriglyceridemia</p>
<p><b>Postmarketing reports</b>: Hyperkalemia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Blood glucose increased, blood potassium decreased</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood uric acid increased</p>
<p><b>Frequency not reported</b>: Hyperglycemia, glycosuria, hyperuricemia</p>
<p><b>Postmarketing reports</b>: Anorexia, loss of appetite</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Hypertriglyceridemia, hyperglycemia, hyperuricemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood glucose increased, blood potassium decreased, blood uric acid increased</p>
<p><b>Rare</b> (less than 0.1%): Hyperkalemia</p>
<p><b>Frequency not reported</b>: Hypercholesterolemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): GGT increased, AST increased, ALT increased</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Uncommon</b> (0.1% to 1%): ALT increased, AST increased, GGT increased</p>
<p><b>Frequency not reported</b>: Pancreatitis, intrahepatic cholestatic jaundice</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): ALT increased, AST increased, GGT increased<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Hematuria, urinary tract infection</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Urinary tract infection, hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety, insomnia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Uncommon</b> (0.1% to 1%): Anxiety, insomnia</p>
<p><b>Frequency not reported</b>: Restlessness</p>
<p><b>Postmarketing reports</b>: Sleep disturbances, depression</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Insomnia</p>
<p><b>Uncommon</b> (0.1% to 1%): Anxiety<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, facial edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Eczema</p>
<p><b>Postmarketing reports</b>: Alopecia, pruritus, urticaria</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Purpura, photosensitivity, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis</p>
<p><b>Postmarketing reports</b>: Rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus, erythematosus</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Rash</p>
<p><b>Postmarketing reports</b>: Alopecia, pruritus, urticaria<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza</p>
<p><b>Uncommon</b> (0.1% to 1%): Viral infection</p>
<p><b>Frequency not reported</b>: Angioedema</p>
<p><b>Postmarketing reports</b>: Anaphylactic reactions</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Uncommon</b> (0.1% to 1%): Influenza, viral infection</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Common</b> (1% to 10%): Influenza</p>
<p><b>Uncommon</b> (0.1% to 1%): Viral infection</p>
<p><b>Postmarketing reports</b>: Angioedema, anaphylactic reactions<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased</p>
<p><b>Postmarketing reports</b>: Acute renal failure</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased</p>
<p><b>Frequency not reported</b>: Renal failure, renal dysfunction, interstitial nephritis</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased</p>
<p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Palpitations, hypotension, orthostatic hypotension</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Vasculitis, cutaneous vasculitis</p>
<p><b>Postmarketing reports</b>: Cardiac arrhythmias, postural hypotension</p>
<p></p>
<p>Olmesartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Tachycardia, angina pectoris</p>
<p><b>Rare</b> (less than 0.1%): Hypotension<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia</p>
<p><b>Postmarketing reports</b>: Bone marrow depression<sup>[Ref]</sup></p><h3>Ocular</h3><p>Ocular side effects have included idiosyncratic reactions to the hydrochlorothiazide component resulting in acute transient myopia and acute angle-closure glaucoma.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Benicar HCT (hydrochlorothiazide-olmesartan)." Sankyo Parke Davis, Parsippany, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about hydrochlorothiazide / olmesartan</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>30 Reviews</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (4)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Olmesartan and hydrochlorothiazide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Benicar HCT</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hydrochlorothiazide / olmesartan: oral tablet</i></p><h3>General</h3><p>The most common side effect was dizziness.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p><b>Uncommon</b> (0.1% to 1%): Syncope</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p><b>Postmarketing reports</b>: Lightheadedness, paresthesia</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Dizziness, headache<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Bronchitis, pharyngitis, sinusitis, upper respiratory tract infection, coughing, nasopharyngitis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Bronchitis, nasopharyngitis, pharyngitis</p><p><b>Uncommon</b> (0.1% to 1%): Sinusitis, upper respiratory tract infection, cough</p><p><b>Frequency not reported</b>: Pneumonitis, pulmonary edema</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Bronchitis, nasopharyngitis, sinusitis, upper respiratory tract infection, cough, pharyngitis, rhinitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Vertigo, Influenza-like symptoms, chest pain, fatigue, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Weakness</p><p><b>Postmarketing reports</b>: Asthenia, lethargy, malaise</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Vertigo, influenza-like symptoms</p><p><b>Uncommon</b> (0.1% to 1%): Chest pain, fatigue, peripheral edema</p><p><b>Frequency not reported</b>: Weakness, fever</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Vertigo, chest pain, fatigue, influenza-like symptoms, peripheral edema, pain</p><p><b>Postmarketing reports</b>: Asthenia, lethargy, malaise<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, gastroenteritis, nausea, abdominal pain, dyspepsia</p><p><b>Postmarketing reports</b>: Sprue-like enteropathy, vomiting</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Diarrhea, dyspepsia, nausea, gastroenteritis</p><p><b>Frequency not reported</b>: Sialadenitis, cramping, gastric irritation</p><p><b>Postmarketing reports</b>: Constipation</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, nausea, gastroenteritis, abdominal pain</p><p><b>Postmarketing reports</b>: Vomiting, sprue-like enteropathy<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, creatine phosphokinase increased, arthralgia, arthritis, myalgia</p><p><b>Uncommon</b> (0.1% to 1%): Pain in limb, spinal disorder</p><p><b>Postmarketing reports</b>: Rhabdomyolysis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Arthralgia, back pain, pain in limb</p><p><b>Uncommon</b> (0.1% to 1%): Spinal disorder</p><p><b>Frequency not reported</b>: Muscle spasm</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Arthralgia, back pain, pain in limb, arthritis, skeletal pain, creatine phosphokinase increased</p><p><b>Uncommon</b> (0.1% to 1%): Spinal disorder, myalgia</p><p><b>Postmarketing reports</b>: Rhabdomyolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperlipemia, hyperglycemia, blood uric acid increased, hyperuricemia</p><p><b>Uncommon</b> (0.1% to 1%): Blood glucose increased, blood potassium decreased, blood potassium increased, hypertriglyceridemia</p><p><b>Postmarketing reports</b>: Hyperkalemia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Blood glucose increased, blood potassium decreased</p><p><b>Uncommon</b> (0.1% to 1%): Blood uric acid increased</p><p><b>Frequency not reported</b>: Hyperglycemia, glycosuria, hyperuricemia</p><p><b>Postmarketing reports</b>: Anorexia, loss of appetite</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Hypertriglyceridemia, hyperglycemia, hyperuricemia</p><p><b>Uncommon</b> (0.1% to 1%): Blood glucose increased, blood potassium decreased, blood uric acid increased</p><p><b>Rare</b> (less than 0.1%): Hyperkalemia</p><p><b>Frequency not reported</b>: Hypercholesterolemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): GGT increased, AST increased, ALT increased</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): ALT increased, AST increased, GGT increased</p><p><b>Frequency not reported</b>: Pancreatitis, intrahepatic cholestatic jaundice</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): ALT increased, AST increased, GGT increased<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Hematuria, urinary tract infection</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Urinary tract infection, hematuria<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety, insomnia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Anxiety, insomnia</p><p><b>Frequency not reported</b>: Restlessness</p><p><b>Postmarketing reports</b>: Sleep disturbances, depression</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Insomnia</p><p><b>Uncommon</b> (0.1% to 1%): Anxiety<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash, facial edema</p><p><b>Uncommon</b> (0.1% to 1%): Eczema</p><p><b>Postmarketing reports</b>: Alopecia, pruritus, urticaria</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Purpura, photosensitivity, urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis</p><p><b>Postmarketing reports</b>: Rash, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus, erythematosus</p><p></p><p>Olmesartan:</p><p><b>Uncommon</b> (0.1% to 1%): Rash</p><p><b>Postmarketing reports</b>: Alopecia, pruritus, urticaria<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza</p><p><b>Uncommon</b> (0.1% to 1%): Viral infection</p><p><b>Frequency not reported</b>: Angioedema</p><p><b>Postmarketing reports</b>: Anaphylactic reactions</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Influenza, viral infection</p><p><b>Frequency not reported</b>: Anaphylactic reactions</p><p></p><p>Olmesartan:</p><p><b>Common</b> (1% to 10%): Influenza</p><p><b>Uncommon</b> (0.1% to 1%): Viral infection</p><p><b>Postmarketing reports</b>: Angioedema, anaphylactic reactions<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased</p><p><b>Postmarketing reports</b>: Acute renal failure</p><p></p><p>Hydrochlorothiazide:</p><p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased</p><p><b>Frequency not reported</b>: Renal failure, renal dysfunction, interstitial nephritis</p><p></p><p>Olmesartan:</p><p><b>Uncommon</b> (0.1% to 1%): Blood creatinine increased</p><p><b>Postmarketing reports</b>: Acute renal failure<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Palpitations, hypotension, orthostatic hypotension</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Vasculitis, cutaneous vasculitis</p><p><b>Postmarketing reports</b>: Cardiac arrhythmias, postural hypotension</p><p></p><p>Olmesartan:</p><p><b>Uncommon</b> (0.1% to 1%): Tachycardia, angina pectoris</p><p><b>Rare</b> (less than 0.1%): Hypotension<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia</p><p><b>Postmarketing reports</b>: Bone marrow depression<sup>[Ref]</sup></p><h3>Ocular</h3><p>Ocular side effects have included idiosyncratic reactions to the hydrochlorothiazide component resulting in acute transient myopia and acute angle-closure glaucoma.<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Benicar HCT (hydrochlorothiazide-olmesartan)." Sankyo Parke Davis, Parsippany, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about hydrochlorothiazide / olmesartan</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>30 Reviews</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (4)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Olmesartan and hydrochlorothiazide &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>